Literature DB >> 769825

Characterization of a replication mutant of the bacteriocinogenic plasmid Clo DF13.

E Veltkamp, H J Nijkamp.   

Abstract

In a previous paper (Kool, A.J. and Nijkamp, H.J.J. (1974) J. Bacteriol. 120, 569--578) the isolation of a mutant of the bacteriocinogenic plasmid Clo DF13-Rep3, has been described. It was observed that cells harbouring the wild type plasmid synthesize more plasmid DNA cells harbouring the wild type plasmid. This paper deals with the characterization of the nature of this plasmid-specific mutation. The following properties of the Clo DF13-Rep3 mutant plasmid could be observed: 1. The plasmid-specific mutation did not lead to a significant change in the sedimentation value of Clo DF13 DNA. 2. The specific rate of Clo DF13-Rep3 DNA synthesis (expressed as the number of plasmid DNA molecules synthesized per min) is on average seven times the specific rate of wild type Clo DF13 DNA synthesis. 3. Also chromosomeless minicells, harbouring the Clo DF 13-Rep 3 plasmid, contain about seven times more plasmid DNA as wild type Clo DF13 harbouring minicells. 4. The replication time of the Clo DF13-Rep3 plasmid is approx. 90 s at 30 degrees C and does not differ significantly from the replication time of the wild type plasmid. 5. The Rep3 mutation did not alter the dependence of Clo DF13 plasmid replication on the dnaA and dnaC gene products. 6. The plasmid-specific mutation is cis-dominant over wild type. The data presented in this paper indicate that this mutant plasmid is not affected in the elongation but in the initiation of plasmid DNA replication.

Mesh:

Year:  1976        PMID: 769825     DOI: 10.1016/0005-2787(76)90263-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  In vitro construction of deletion mutants of the bacteriocinogenic plasmid Clo DF13.

Authors:  A R Stuitje; E Veltkamp; P J van den Elzen; H J Nijkamp
Journal:  Nucleic Acids Res       Date:  1978-06       Impact factor: 16.971

2.  Isolation and characterization of a Clo DF13::Tn901 plasmid mutant with thermosensitive control of DNA replication.

Authors:  P M Andreoli; R A Brandsma; E Veltkamp; H J Nijkamp
Journal:  J Bacteriol       Date:  1978-08       Impact factor: 3.490

3.  Origin and direction of replication of the bacteriocinogenic plasmid Clo DF13.

Authors:  A R Stuitje; E Veltkamp; P J Weijers; H J Nijkamp
Journal:  Nucleic Acids Res       Date:  1979-01       Impact factor: 16.971

Review 4.  Regulation of plasmid replication.

Authors:  J R Scott
Journal:  Microbiol Rev       Date:  1984-03

5.  Molecular structure of the immunity gene and immunity protein of the bacteriocinogenic plasmid Clo DF13.

Authors:  P J van den Elzen; W Gaastra; C E Spelt; F K de Graaf; E Veltkamp; H J Nijkamp
Journal:  Nucleic Acids Res       Date:  1980-10-10       Impact factor: 16.971

6.  Structure and regulation of gene expression of a Clo DF13 plasmid DNA region involved in plasmid segregation and incompatibility.

Authors:  P J van den Elzen; M J Hakkaart; A J van Putten; H H Walters; E Veltkamp; H J Nijkamp
Journal:  Nucleic Acids Res       Date:  1983-12-20       Impact factor: 16.971

7.  Protein H encoded by plasmid Clo DF13 involved in lysis of the bacterial host. II. Functions and regulation of synthesis of the gene H product.

Authors:  M J Hakkaart; E Veltkamp; H J Nijkamp
Journal:  Mol Gen Genet       Date:  1981

8.  Replication control functions of plasmid R1 act as inhibitors of expression of a gene required for replication.

Authors:  J Light; S Molin
Journal:  Mol Gen Genet       Date:  1981

9.  Transcription of bacteriocinogenic plasmid CloDF13 in vivo and in vitro: structure of the cloacin immunity operon.

Authors:  P J van den Elzen; R N Konings; E Veltkamp; H J Nijkamp
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

10.  Mitomycin C-induced synthesis of cloacin DF13 and lethality in cloacinogenic Escherichia coli cells.

Authors:  G J van Tiel-Menkveld; E Veltkamp; F K De Graaf
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.